Using ice and anti-inflammatory medication to reduce swelling
Clinical trials show semaglutide produces an average of ~15% body weight loss at 68 weeks, while tirzepatide has demonstrated up to 20.9% weight loss at 72 weeks. Patients in our medical weight loss program which include nutrition and muscle preservation support lose an average of 1520% of their excess body weight on injectable GLP-1 medications, which is clinically meaningful and can improve conditions like type 2 diabetes, high blood pressure, and sleep apnea
Degenerative TFCC Tear These tears develop gradually over time due to natural wear and tear or repetitive stress
LipoStat Plus: This injectable contains a blend of amino acids and vitamins that help break down fat, boost energy, and preserve lean muscle mass, making it an ideal supplement for individuals undergoing medical weight loss treatment
Storage and Reconstitution Storage (lyophilized) : -20C or colder After reconstitution : Store at 28C and use within 30 days Solvents : Sterile bacteriostatic water (BAC water) or sterile saline Shelf Life : 24 months from production (lyophilized) Safety and Handling PT141 is supplied for laboratory research use only